BlackRock Japan’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$47M Buy
+1,297,628
New +$47M 0.16% 151
2016
Q3
Sell
-9,760
Closed -$490K 1415
2016
Q2
$490K Sell
9,760
-1,637
-14% -$82.2K ﹤0.01% 723
2016
Q1
$610K Sell
11,397
-307,148
-96% -$16.4M ﹤0.01% 735
2015
Q4
$20.9M Buy
318,545
+26,569
+9% +$1.74M 0.08% 286
2015
Q3
$16.5M Buy
291,976
+48,310
+20% +$2.73M 0.07% 324
2015
Q2
$14.4M Sell
243,666
-109,690
-31% -$6.48M 0.06% 387
2015
Q1
$22M Buy
353,356
+22,380
+7% +$1.39M 0.09% 264
2014
Q4
$19M Buy
330,976
+7,585
+2% +$436K 0.07% 308
2014
Q3
$17.4M Buy
323,391
+11,944
+4% +$642K 0.08% 293
2014
Q2
$16.3M Buy
311,447
+58,494
+23% +$3.07M 0.07% 298
2014
Q1
$13.4M Buy
252,953
+235,753
+1,371% +$12.5M 0.06% 372
2013
Q4
$689K Buy
17,200
+7,000
+69% +$280K ﹤0.01% 742
2013
Q3
$385K Buy
10,200
+2,500
+32% +$94.4K ﹤0.01% 780
2013
Q2
$302K Buy
+7,700
New +$302K ﹤0.01% 798